Feature | May 11, 2012

ACCF, SCAI Publish New Standards Defining Best Practices for Modern Cardiac Cath Labs

Changes in Technology, Clinical Practice Prompt Updated Recommendations

May 11, 2012 — Modern cardiac catheterization laboratories bear scant resemblance to the cath labs of a decade ago. An updated consensus statement released this week offers physicians guidance on how to excel in this new diagnostic and therapeutic milieu, with specific recommendations on setting up, operating and maintaining the highest standards of quality in a contemporary cardiac cath lab.

The consensus statement was developed by a panel of the American College of Cardiology Foundation (ACCF) and the Society for Cardiovascular Angiography and Interventions (SCAI), in collaboration with the Society of Thoracic Surgeons and the Society for Vascular Medicine. It updates a similar document released in 2001.

“There have been a lot of changes since 2001, some of them dramatic,” said Thomas M. Bashore, M.D., writing committee chair and professor of medicine and clinical chief of cardiology at Duke University Medical Center, Durham, N.C. “This document sets the stage for what’s really happening in cath labs today and updates everyone on accepted quality standards and best practices.”

Among the changes has been a shift in focus from diagnostic tests to catheter-based therapies, from coronary disease alone to include the treatment of valvular heart disease, congenital defects of the heart and arterial disease in the legs, brain and other organs. An increasing number of medical centers are developing hybrid cath labs that combine all the features of a surgical suite with those of a cath lab. And pediatric cath labs—now devoted almost exclusively to therapy—apply minimally invasive catheter techniques to congenital disease that once required major heart surgery, with procedures now being performed on unborn fetuses and newborns, as well as older children.

The new consensus statement addresses the features of modern cath labs, including:  

  • Cardiac catheterization laboratories without on-site cardiac surgical backup: Today, up to one-third of angiograms and percutaneous coronary interventions (PCIs) are performed in cath labs without on-site surgery. The consensus document states the risk of major complications with most invasive coronary procedures is very low and proposes requirements for establishing off-site surgical backup while lifting many prior restrictions on the types of patients eligible for such procedures.
  • PCI for heart attack patients in hospitals without on-site cardiac surgical backup: The authors stress that partnership with a major medical center with cardiac surgery capability is mandatory, including the establishment of a written plan for transfer should complications arise. The document withholds endorsement of programs that offer PCI for heart attack only during daytime business hours (no nights or weekends).
  • Minimum case volumes for diagnostic cardiac catheterization: The authors found no data to support the use of minimum case volumes as an indicator of physician quality in performing diagnostic cardiac catheterization. Instead, they state that an effective quality assurance program is the key to ensuring that cardiac catheterization studies are appropriate, and performed and interpreted correctly. A related document is in development and will address minimal case volume for physicians who perform PCI procedures.
  • Quality assurance/quality improvement programs: The new standards document defines essential elements of a quality assurance/quality improvement program, including participation in a national clinical database, tracking of specific quality indicators, benchmarking against peers, and monitoring of procedure appropriateness and quality.
  • Hybrid cath labs: The authors review in detail the role of the hybrid cath lab, including the types of procedures suitable for a hybrid lab and special considerations in designing, building and equipping the lab.
  • Training requirements: The document outlines the current training requirements for physicians who perform invasive and interventional procedures in the coronary and peripheral arteries, and for the treatment of structural heart disease.
  • Pre-procedural preparation: The authors recommend steps to protect kidney function during invasive procedures, including ensuring adequate hydration, shortening the time patients are instructed to go without drinking before the procedure and linking the maximum volume of contrast media to pre-catheterization kidney function tests. The document also suggests a routine protime is no longer required before the catheterization unless there is a reason to suspect an abnormality.
  • Imaging: The authors also summarize major changes in X-ray imaging, with the adoption of digital image acquisition, display and storage.
  • Radiation safety: The document outlines techniques to reduce radiation exposure to cath lab patients and staff.
  • Treatment of infants and children: The authors explore in depth special concerns involving the pediatric cardiac catheterization laboratory.


Consensus documents serve many purposes, but the most important is to define high-quality clinical practice, Bashore said.

“We don’t always have randomized clinical trials to rely on,” he said. “The purpose of this document is to define a practice standard for how you set up and run a cath lab, the people in the cath lab, the quality assurance programs—all the things cath lab teams should be thinking about.”

The document can be accessed at www.cardiosource.org and www.SCAI.org. It will also be published in the June 5, 2012, issue of the Journal of the American College of Cardiology and in a forthcoming issue of Catheterization and Cardiovascular Interventions.

Related Content

FDA, CDRH, national evaluation system, medical device development
Feature | Business| May 04, 2016
The U.S. Food and Drug Administration (FDA) announced it is building the foundations of a national evaluation system to...
radiation dose in the cath lab
News | Radiation Dose Management| May 02, 2016
May 2, 2016 — Starting at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 annual meeting May
Feature | Business| April 28, 2016 | Dave Fornell
 
Technology | Stents Peripheral| April 27, 2016
Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a patient suffering...
Auris Surgical Robotics, acquisition, Hansen Medical
News | Robotic Systems| April 26, 2016
Auris Surgical Robotics Inc. and Hansen Medical Inc. announced that they have signed a definitive merger agreement...
Siemens Sensis Vibe, hemodyanamics system

Siemens released the Sensis Vibe hemodyanamics system at ACC.16. The newer system offers better integration of cath lab data into cath lab reports and the electronic medical record (EMR).

Feature | ACC| April 25, 2016 | Jon Brubaker, MBA, RCVT, Tom Watson, BS, RCVT, and Sabrina Newell MS, RCS
There were several trends seen in new cardiovascular technologies showcased on the expo floor at the 2016 American...
Medtronic, Drug-Filled Stent, RevElution Trial results, ACC.16, CE Mark
News | Stents Drug Eluting| April 21, 2016
Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its novel, next-...
Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall
News | Thrombectomy Devices| April 20, 2016
April 20, 2016 — Boston Scientific Corp. announced a U.S.
ischemic postconditioning, STEMI patients, clinical outcomes, ACC.16
News | Cath Lab| April 19, 2016
A large randomized controlled trial of ischemic postconditioning in patients who had experienced ST-segment elevation...
STEMI, delayed or deferred stent implantation, DANAMI-3-DEFER trial, ACC.16
News | Cath Lab| April 18, 2016
Delayed or deferred stent implantation in patients showed no clinical benefit in patients experiencing the deadliest...
Overlay Init